MA71728A - Dérivés bicycliques de tétrahydrothiazépine - Google Patents
Dérivés bicycliques de tétrahydrothiazépineInfo
- Publication number
- MA71728A MA71728A MA71728A MA71728A MA71728A MA 71728 A MA71728 A MA 71728A MA 71728 A MA71728 A MA 71728A MA 71728 A MA71728 A MA 71728A MA 71728 A MA71728 A MA 71728A
- Authority
- MA
- Morocco
- Prior art keywords
- tetrahydrothiazepine
- bicyclic
- derivatives
- tetrahydrothiazepine derivatives
- bicyclic tetrahydrothiazepine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22189820 | 2022-08-11 | ||
| EP23754299.8A EP4568959A1 (fr) | 2022-08-11 | 2023-08-09 | Dérivés bicycliques de tétrahydrothiazépine |
| PCT/EP2023/071990 WO2024033389A1 (fr) | 2022-08-11 | 2023-08-09 | Dérivés bicycliques de tétrahydrothiazépine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA71728A true MA71728A (fr) | 2025-05-30 |
Family
ID=82899256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA71728A MA71728A (fr) | 2022-08-11 | 2023-08-09 | Dérivés bicycliques de tétrahydrothiazépine |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20260138976A1 (fr) |
| EP (1) | EP4568959A1 (fr) |
| JP (1) | JP2025526681A (fr) |
| KR (1) | KR20250048020A (fr) |
| CN (1) | CN119677733A (fr) |
| AR (1) | AR130168A1 (fr) |
| AU (1) | AU2023322638A1 (fr) |
| CA (1) | CA3262845A1 (fr) |
| CL (1) | CL2025000381A1 (fr) |
| CO (1) | CO2025003011A2 (fr) |
| CR (1) | CR20250043A (fr) |
| IL (1) | IL316935A (fr) |
| MA (1) | MA71728A (fr) |
| MX (1) | MX2025000919A (fr) |
| PE (1) | PE20250876A1 (fr) |
| TW (1) | TW202417002A (fr) |
| WO (1) | WO2024033389A1 (fr) |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US533A (en) | 1837-12-26 | Truss for hermta | ||
| US4943A (en) | 1847-01-26 | Harness-buckle | ||
| CU22545A1 (es) | 1994-11-18 | 1999-03-31 | Centro Inmunologia Molecular | Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico |
| DE69025946T2 (de) | 1989-09-08 | 1996-10-17 | Univ Duke | Modifikationen der struktur des egf-rezeptor-gens in menschlichen glioma |
| AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
| GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
| ATE207366T1 (de) | 1993-12-24 | 2001-11-15 | Merck Patent Gmbh | Immunokonjugate |
| IL112249A (en) | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| IL112248A0 (en) | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| US5654307A (en) | 1994-01-25 | 1997-08-05 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| KR100441557B1 (ko) | 1994-07-21 | 2005-08-05 | 아크조 노벨 엔.브이. | 고리형케톤과산화물조성물 |
| US5804396A (en) | 1994-10-12 | 1998-09-08 | Sugen, Inc. | Assay for agents active in proliferative disorders |
| ATE446955T1 (de) | 1995-03-30 | 2009-11-15 | Pfizer Prod Inc | Chinazolinone derivate |
| GB9508565D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quiazoline derivative |
| GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| CA2222231A1 (fr) | 1995-06-07 | 1996-12-19 | Imclone Systems Incorporated | Anticorps et fragments d'anticorps inhibant la croissance des tumeurs |
| PL188959B1 (pl) | 1995-07-06 | 2005-05-31 | Novartis Ag | Pirolopirymidyny i sposoby ich wytwarzania |
| US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| CN100503580C (zh) | 1996-04-12 | 2009-06-24 | 沃尼尔·朗伯公司 | 酪氨酸激酶的不可逆抑制剂 |
| US6391874B1 (en) | 1996-07-13 | 2002-05-21 | Smithkline Beecham Corporation | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| ID18494A (id) | 1996-10-02 | 1998-04-16 | Novartis Ag | Turunan pirazola leburan dan proses pembuatannya |
| UA73073C2 (uk) | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| US6002008A (en) | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| AU7165698A (en) | 1997-05-06 | 1998-11-27 | American Cyanamid Company | Use of quinazoline compounds for the treatment of polycystic kidney disease |
| ZA986732B (en) | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitiors of tyrosine kinases |
| ZA986729B (en) | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitors of tyrosine kinases |
| TW436485B (en) | 1997-08-01 | 2001-05-28 | American Cyanamid Co | Substituted quinazoline derivatives |
| AU1308799A (en) | 1997-11-06 | 1999-05-31 | American Cyanamid Company | Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps |
| CN1160338C (zh) | 1998-11-19 | 2004-08-04 | 沃尼尔·朗伯公司 | N-[4-(3-氯-4-氟-苯基氨基)-7-(3-吗啉-4-基-丙氧基)-喹唑啉-6-基]-丙烯酰胺,不可逆的酪氨酸激酶抑制剂 |
| TWI309240B (en) | 2004-09-17 | 2009-05-01 | Hoffmann La Roche | Anti-ox40l antibodies |
| JP5238936B2 (ja) | 2005-03-25 | 2013-07-17 | ジーアイティーアール,インク. | Gitr結合分子およびその使用 |
| DK1879573T3 (da) | 2005-05-10 | 2013-02-25 | Incyte Corp | Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf |
| KR101704734B1 (ko) | 2005-07-01 | 2017-02-09 | 이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. | 예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체 |
| ES2540561T3 (es) | 2005-12-20 | 2015-07-10 | Incyte Corporation | N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa |
| CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
| CA2663057C (fr) | 2006-09-19 | 2015-12-08 | Incyte Corporation | N-hydroxyamidinoheterocycles en tant que modulateurs d'indoleamine 2,3-dioxygenase |
| EP1987839A1 (fr) | 2007-04-30 | 2008-11-05 | I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale | Anticorps monoclonal cytotoxique anti-LAG-3 et son utilisation pour le traitement ou la prévention d'un rejet de greffe d'organe et de maladies auto-immunes |
| PT2175884T (pt) | 2007-07-12 | 2016-09-21 | Gitr Inc | Terapias de combinação empregando moléculas de ligação a gitr |
| EP2044949A1 (fr) | 2007-10-05 | 2009-04-08 | Immutep | Utilisation de lag-3 recombinant ou ses dérivatifs pour déclencher la réponse immune des monocytes |
| WO2009073620A2 (fr) | 2007-11-30 | 2009-06-11 | Newlink Genetics | Inhibiteurs de l'ido |
| AU2008353145B2 (en) | 2008-01-03 | 2013-09-12 | Universite D' Aix-Marseille | Bitherapy and tritherapy used for treating an HIV-positive patient |
| AR072999A1 (es) | 2008-08-11 | 2010-10-06 | Medarex Inc | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos |
| MX356367B (es) | 2008-12-09 | 2018-05-25 | Genentech Inc | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t. |
| IN2015DN02826A (fr) | 2009-09-03 | 2015-09-11 | Merck Sharp & Dohme | |
| EP2493862B1 (fr) | 2009-10-28 | 2016-10-05 | Newlink Genetics Corporation | Dérivés imidazole comme inhibiteurs de l'ido |
| DK2542256T3 (da) | 2010-03-04 | 2019-08-26 | Macrogenics Inc | Antistoffer reagerende med b7-h3, immunologisk aktive fragmenter deraf og anvendelser deraf |
| NZ729044A (en) | 2010-09-09 | 2020-07-31 | Pfizer | 4-1bb binding molecules |
| NO2694640T3 (fr) | 2011-04-15 | 2018-03-17 | ||
| CA2833636A1 (fr) | 2011-04-20 | 2012-10-26 | Amplimmune, Inc. | Anticorps et autres molecules qui se lient a b7-h1 et a pd-1 |
| AR091649A1 (es) | 2012-07-02 | 2015-02-18 | Bristol Myers Squibb Co | Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos |
| RU2015105561A (ru) * | 2012-08-09 | 2016-09-27 | Ф. Хоффманн-Ля Рош Аг | Замещенные гетероазепиноны |
| JP6727224B2 (ja) * | 2015-03-02 | 2020-07-22 | アペイロン・バイオロジックス・アクチェンゲゼルシャフトAPEIRON Biologics AG | 新生物疾患および/または感染性疾患の治療にとって有用な二環式テトラヒドロチアゼピン誘導体 |
| MX2023009379A (es) * | 2021-02-12 | 2023-10-10 | Hoffmann La Roche | Derivados de tetrahidroazepina biciclicos para el tratamiento del cancer. |
-
2023
- 2023-08-09 CN CN202380058935.2A patent/CN119677733A/zh active Pending
- 2023-08-09 US US19/101,062 patent/US20260138976A1/en active Pending
- 2023-08-09 JP JP2025507310A patent/JP2025526681A/ja active Pending
- 2023-08-09 CR CR20250043A patent/CR20250043A/es unknown
- 2023-08-09 MA MA71728A patent/MA71728A/fr unknown
- 2023-08-09 AU AU2023322638A patent/AU2023322638A1/en active Pending
- 2023-08-09 IL IL316935A patent/IL316935A/en unknown
- 2023-08-09 EP EP23754299.8A patent/EP4568959A1/fr active Pending
- 2023-08-09 CA CA3262845A patent/CA3262845A1/fr active Pending
- 2023-08-09 WO PCT/EP2023/071990 patent/WO2024033389A1/fr not_active Ceased
- 2023-08-09 KR KR1020257005927A patent/KR20250048020A/ko active Pending
- 2023-08-09 PE PE2025000213A patent/PE20250876A1/es unknown
- 2023-08-10 AR ARP230102109A patent/AR130168A1/es unknown
- 2023-08-10 TW TW112130082A patent/TW202417002A/zh unknown
-
2025
- 2025-01-23 MX MX2025000919A patent/MX2025000919A/es unknown
- 2025-02-10 CL CL2025000381A patent/CL2025000381A1/es unknown
- 2025-03-07 CO CONC2025/0003011A patent/CO2025003011A2/es unknown
- 2025-07-25 US US19/280,486 patent/US20260151404A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4568959A1 (fr) | 2025-06-18 |
| KR20250048020A (ko) | 2025-04-07 |
| TW202417002A (zh) | 2024-05-01 |
| US20260138976A1 (en) | 2026-05-21 |
| AR130168A1 (es) | 2024-11-13 |
| CN119677733A (zh) | 2025-03-21 |
| CR20250043A (es) | 2025-03-25 |
| AU2023322638A1 (en) | 2024-11-28 |
| CO2025003011A2 (es) | 2025-03-27 |
| US20260151404A1 (en) | 2026-06-04 |
| JP2025526681A (ja) | 2025-08-15 |
| WO2024033389A1 (fr) | 2024-02-15 |
| CL2025000381A1 (es) | 2025-04-21 |
| MX2025000919A (es) | 2025-03-07 |
| IL316935A (en) | 2025-01-01 |
| PE20250876A1 (es) | 2025-03-28 |
| CA3262845A1 (fr) | 2024-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4120820A4 (fr) | Dérivés cristallins de psilacétine | |
| EP4038058A4 (fr) | Dérivés de cannabinoïdes | |
| EP3911631A4 (fr) | Nouveaux dérivés de sulfonylurées substitués | |
| EP4308577C0 (fr) | Nouveaux dérivés de thiadiazolopyrimidone | |
| MA56504A (fr) | Dérivés de pyridin-3-yle | |
| MA71727A (fr) | Dérivés bicycliques de tétrahydrothiazépine | |
| EP4229062A4 (fr) | Composés bicycliques | |
| EP4166541A4 (fr) | Dérivé de diméthylsulfoximines | |
| EP4502309A4 (fr) | Urinoir | |
| JP1749680S (ja) | 取付用小便器 | |
| EP4361159A4 (fr) | Dérivé de borono-phénylalanine | |
| EP4157845C0 (fr) | Dérivés de pyrrolo [2,3-d] pyrimidine | |
| IL316935A (en) | TETRAHYDROTHIAZEPINE DERIVATIVES CYCLES | |
| MA53541A (fr) | Dérivés hétéroaryles bicycliques | |
| JP1782793S (ja) | 取付用小便器 | |
| JP1782718S (ja) | 取付用小便器 | |
| JP1782796S (ja) | 取付用小便器 | |
| JP1782794S (ja) | 取付用小便器 | |
| JP1782795S (ja) | 取付用小便器 | |
| JP1749679S (ja) | 取付用小便器 | |
| JP1749678S (ja) | 取付用小便器 | |
| JP1749677S (ja) | 取付用小便器 | |
| JP1749682S (ja) | 取付用小便器 | |
| JP1749681S (ja) | 取付用小便器 | |
| JP1749652S (ja) | 取付用小便器 |